| 000 | 02395nam a2200457 i 4500 | ||
|---|---|---|---|
| 001 | EBC3564286 | ||
| 003 | MiAaPQ | ||
| 005 | 20240123154144.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 140127t20132013dcuab ob 000 0 eng|d | ||
| 020 | _z0309269393 (pbk.) | ||
| 020 | _z9780309269391 (pbk.) | ||
| 020 |
_a9780309269407 _q(electronic bk.) |
||
| 035 | _a(MiAaPQ)EBC3564286 | ||
| 035 | _a(Au-PeEL)EBL3564286 | ||
| 035 | _a(CaPaEBR)ebr10863743 | ||
| 035 | _a(OCoLC)839275199 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aHD9665.5 _b.I57 2013 |
|
| 110 | 2 |
_aInstitute of Medicine (U.S.). _bCommittee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, _eissuing body. |
|
| 245 | 1 | 0 |
_aCountering the problem of falsified and substandard drugs / _cCommittee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies. |
| 264 | 1 |
_aWashington, District of Columbia : _bNational Academies Press, _c[2013] |
|
| 264 | 4 | _c2013 | |
| 300 |
_a1 online resource (375 pages) : _billustrations (chiefly color), color maps |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references. | ||
| 588 | _aDescription based on print version record. | ||
| 590 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 |
_aPharmaceutical industry _xQuality control. |
|
| 650 | 0 |
_aFraud _xPrevention. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aBuckley, Gillian J., _eeditor. |
|
| 700 | 1 |
_aGostin, Lawrence O. _q(Lawrence Ogalthorpe), _eeditor. |
|
| 710 | 2 |
_aInstitute of Medicine. _bBoard on Global Health, _eissuing body. |
|
| 776 | 0 | 8 |
_iPrint version: _aInstitute of Medicine (U.S.). _tCountering the problem of falsified and substandard drugs. _dWashington, District of Columbia : National Academies Press, [2013] _hxxiv, 351 pages ; 23 cm _z9780309269391 _w(DLC)18019897 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3564286 _zClick to View |
| 999 |
_c233938 _d233937 |
||